RAMP · LiveRamp Holdings, Inc.

Current Thesis

LiveRamp’s thesis remains completion of Publicis’ $38.50-per-share cash acquisition before year-end 2026; regulatory approvals and an announced closing would settle it. Publicis reaffirmed that timetable on 2026-09-16 while announcing financing intended partly for the acquisition. The completion case is invalidated by a daily close below $35, termination of the agreement, or failure to complete by 2026-12-31. Publicis announcement, 2026-09-16

The material development since the 2026-09-06 note is financing preparation: Publicis priced €500 million of bonds, with proceeds contributing to the acquisition. This supports an inference of continued commitment, but the announcement still makes completion subject to approvals. The narrative is maturing — the 2026-08-17 shareholder approval and 2026-09-16 financing announcement place the transaction in its execution phase. Neither event establishes regulatory clearance. Publicis financing announcement

Bullish and bearish views on LiveRamp Holdings, Inc.

The model's bull view on LiveRamp Holdings, Inc. (RAMP), in brief: Shareholders have approved the agreement. The bear view: Financing does not establish clearance. Publicis’ 2026-09-16 release explicitly retained the approvals condition without identifying completed regulatory reviews. It cannot substantiate a claim that the transaction is cleared. Publicis announcement The standalone reference… Both cases follow in full.

Bull Case

• Shareholders have approved the agreement. At the 2026-08-17 special meeting, 51,578,202 votes supported adoption and 60,073 opposed it. This removes the shareholder-approval condition. LiveRamp Form 8-K, Item 5.07
• Cash consideration remains contractually specified. The agreement dated 2026-05-16 provides $38.50 per share in cash; the previously published merger terms identify no financing condition. Completion at that consideration is the defined successful outcome, rather than an assumed expansion in the company’s valuation multiple. LiveRamp merger announcement filing
• The acquirer reiterated its timetable. Publicis’ 2026-09-16 financing announcement retained expected completion before the end of 2026. That statement supports the existing timetable; an announced delay would contradict it. Publicis announcement

Bear Case

• Financing does not establish clearance. Publicis’ 2026-09-16 release explicitly retained the approvals condition without identifying completed regulatory reviews. It cannot substantiate a claim that the transaction is cleared. Publicis announcement
• The standalone reference remains materially lower. The published merger announcement records a pre-announcement close of $29.66 on 2026-05-15, compared with the supplied adjusted close of $37.66 on 2026-09-18. The earlier price is a historical reference, not a forecast of where the shares would trade after termination. Publicis acquisition announcement, 2026-05-17

Setup & Price Structure

The supplied adjusted daily series records a 2026-09-18 close of $37.66, a 52-week high of $38.01 and a three-month price change of 0.1%. The same snapshot places the shares 0.9% below that high and reports a 14-period relative strength index (RSI) of 45.9. These are measured price observations; they do not identify who owns the shares or establish crowded participation.

The published $35 daily-close threshold remains the research invalidation level. It is not a newly measured support shelf: the supplied snapshot contains neither a moving-average value nor the price history needed to establish one. Likewise, no dated fund-flow, short-interest or insider-transaction evidence supports a positioning verdict in this refresh.

The high-conviction completion assessment rests on the 2026-08-17 vote and the signed cash agreement, with regulatory uncertainty preventing a near-certain assessment. Success requires completed payment under the agreement before the price or event invalidation occurs; proximity to the 2026-09-18 reference high alone does not establish that outcome.

Catalyst Calendar (next 30 days)

• 2026-09-30 — Fiscal quarter ends. The fiscal calendar identified in the 2026-03-31 annual reporting context places the end of fiscal Q2 FY2027 on this date. This is an accounting boundary, not an earnings-release date or a regulatory deadline.

As checked on 2026-09-20, the Publicis events page does not confirm a forthcoming Q3 release date. The earlier estimated October event is therefore not treated as a scheduled catalyst. No confirmed regulatory decision date is available for the next 30 days. Publicis events calendar

• 2026-12-31 — Year-end completion checkpoint. This is the calendar endpoint for Publicis’ stated expectation of closing before year-end, reiterated on 2026-09-16; it is not a scheduled closing appointment. An uncompleted transaction at that checkpoint would invalidate the timing component of the thesis. Publicis announcement

What Would Change Our Mind

Loss of the existing completion structure would be recorded by a daily close below $35 in the adjusted price series used for the 2026-09-18 reference close. Agreement termination would independently end the cash-completion thesis. Failure to close by 2026-12-31 would break the stated timetable even if the merger agreement remained effective.

An explicit clearance announcement would improve the evidence only for the approval it names. The 2026-09-16 financing release does not provide that confirmation, so no individual regulatory condition is marked satisfied from that disclosure.

Correlation Notes

This remains a single-name merger situation: the 2026-05-16 agreement specifies fixed cash consideration rather than an exchange into Publicis shares. The inference is that completion news is more directly relevant to the stated case than a broad advertising-software rally; termination of that agreement would remove the premise. LiveRamp merger filing

The 2026-09-18 snapshot supplies no matched return history for Publicis, advertising peers or a market index. The sample is too small to support a measured correlation claim.